Cargando…
Aquatic therapy for boys with Duchenne muscular dystrophy (DMD): an external pilot randomised controlled trial
BACKGROUND: Standard treatment of Duchenne muscular dystrophy (DMD) includes regular physiotherapy. There are no data to show whether adding aquatic therapy (AT) to land-based exercises helps maintain motor function. We assessed the feasibility of recruiting and collecting data from boys with DMD in...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367005/ https://www.ncbi.nlm.nih.gov/pubmed/28357131 http://dx.doi.org/10.1186/s40814-017-0132-0 |
_version_ | 1782517695229460480 |
---|---|
author | Hind, Daniel Parkin, James Whitworth, Victoria Rex, Saleema Young, Tracey Hampson, Lisa Sheehan, Jennie Maguire, Chin Cantrill, Hannah Scott, Elaine Epps, Heather Main, Marion Geary, Michelle McMurchie, Heather Pallant, Lindsey Woods, Daniel Freeman, Jennifer Lee, Ellen Eagle, Michelle Willis, Tracey Muntoni, Francesco Baxter, Peter |
author_facet | Hind, Daniel Parkin, James Whitworth, Victoria Rex, Saleema Young, Tracey Hampson, Lisa Sheehan, Jennie Maguire, Chin Cantrill, Hannah Scott, Elaine Epps, Heather Main, Marion Geary, Michelle McMurchie, Heather Pallant, Lindsey Woods, Daniel Freeman, Jennifer Lee, Ellen Eagle, Michelle Willis, Tracey Muntoni, Francesco Baxter, Peter |
author_sort | Hind, Daniel |
collection | PubMed |
description | BACKGROUND: Standard treatment of Duchenne muscular dystrophy (DMD) includes regular physiotherapy. There are no data to show whether adding aquatic therapy (AT) to land-based exercises helps maintain motor function. We assessed the feasibility of recruiting and collecting data from boys with DMD in a parallel-group pilot randomised trial (primary objective), also assessing how intervention and trial procedures work. METHODS: Ambulant boys with DMD aged 7–16 years established on steroids, with North Star Ambulatory Assessment (NSAA) score ≥8, who were able to complete a 10-m walk test without aids or assistance, were randomly allocated (1:1) to 6 months of either optimised land-based exercises 4 to 6 days/week, defined by local community physiotherapists, or the same 4 days/week plus AT 2 days/week. Those unable to commit to a programme, with >20% variation between NSAA scores 4 weeks apart, or contraindications to AT were excluded. The main outcome measures included feasibility of recruiting 40 participants in 6 months from six UK centres, clinical outcomes including NSAA, independent assessment of treatment optimisation, participant/therapist views on acceptability of intervention and research protocols, value of information (VoI) analysis and cost-impact analysis. RESULTS: Over 6 months, 348 boys were screened: most lived too far from centres or were enrolled in other trials; 12 (30% of the targets) were randomised to AT (n = 8) or control (n = 4). The mean change in NSAA at 6 months was −5.5 (SD 7.8) in the control arm and −2.8 (SD 4.1) in the AT arm. Harms included fatigue in two boys, pain in one. Physiotherapists and parents valued AT but believed it should be delivered in community settings. Randomisation was unattractive to families, who had already decided that AT was useful and who often preferred to enrol in drug studies. The AT prescription was considered to be optimised for three boys, with other boys given programmes that were too extensive and insufficiently focused. Recruitment was insufficient for VoI analysis. CONCLUSIONS: Neither a UK-based RCT of AT nor a twice weekly AT therapy delivered at tertiary centres is feasible. Our study will help in the optimisation of AT service provision and the design of future research. TRIAL REGISTRATION: ISRCTN41002956 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40814-017-0132-0) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5367005 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-53670052017-03-29 Aquatic therapy for boys with Duchenne muscular dystrophy (DMD): an external pilot randomised controlled trial Hind, Daniel Parkin, James Whitworth, Victoria Rex, Saleema Young, Tracey Hampson, Lisa Sheehan, Jennie Maguire, Chin Cantrill, Hannah Scott, Elaine Epps, Heather Main, Marion Geary, Michelle McMurchie, Heather Pallant, Lindsey Woods, Daniel Freeman, Jennifer Lee, Ellen Eagle, Michelle Willis, Tracey Muntoni, Francesco Baxter, Peter Pilot Feasibility Stud Research BACKGROUND: Standard treatment of Duchenne muscular dystrophy (DMD) includes regular physiotherapy. There are no data to show whether adding aquatic therapy (AT) to land-based exercises helps maintain motor function. We assessed the feasibility of recruiting and collecting data from boys with DMD in a parallel-group pilot randomised trial (primary objective), also assessing how intervention and trial procedures work. METHODS: Ambulant boys with DMD aged 7–16 years established on steroids, with North Star Ambulatory Assessment (NSAA) score ≥8, who were able to complete a 10-m walk test without aids or assistance, were randomly allocated (1:1) to 6 months of either optimised land-based exercises 4 to 6 days/week, defined by local community physiotherapists, or the same 4 days/week plus AT 2 days/week. Those unable to commit to a programme, with >20% variation between NSAA scores 4 weeks apart, or contraindications to AT were excluded. The main outcome measures included feasibility of recruiting 40 participants in 6 months from six UK centres, clinical outcomes including NSAA, independent assessment of treatment optimisation, participant/therapist views on acceptability of intervention and research protocols, value of information (VoI) analysis and cost-impact analysis. RESULTS: Over 6 months, 348 boys were screened: most lived too far from centres or were enrolled in other trials; 12 (30% of the targets) were randomised to AT (n = 8) or control (n = 4). The mean change in NSAA at 6 months was −5.5 (SD 7.8) in the control arm and −2.8 (SD 4.1) in the AT arm. Harms included fatigue in two boys, pain in one. Physiotherapists and parents valued AT but believed it should be delivered in community settings. Randomisation was unattractive to families, who had already decided that AT was useful and who often preferred to enrol in drug studies. The AT prescription was considered to be optimised for three boys, with other boys given programmes that were too extensive and insufficiently focused. Recruitment was insufficient for VoI analysis. CONCLUSIONS: Neither a UK-based RCT of AT nor a twice weekly AT therapy delivered at tertiary centres is feasible. Our study will help in the optimisation of AT service provision and the design of future research. TRIAL REGISTRATION: ISRCTN41002956 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40814-017-0132-0) contains supplementary material, which is available to authorized users. BioMed Central 2017-03-27 /pmc/articles/PMC5367005/ /pubmed/28357131 http://dx.doi.org/10.1186/s40814-017-0132-0 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Hind, Daniel Parkin, James Whitworth, Victoria Rex, Saleema Young, Tracey Hampson, Lisa Sheehan, Jennie Maguire, Chin Cantrill, Hannah Scott, Elaine Epps, Heather Main, Marion Geary, Michelle McMurchie, Heather Pallant, Lindsey Woods, Daniel Freeman, Jennifer Lee, Ellen Eagle, Michelle Willis, Tracey Muntoni, Francesco Baxter, Peter Aquatic therapy for boys with Duchenne muscular dystrophy (DMD): an external pilot randomised controlled trial |
title | Aquatic therapy for boys with Duchenne muscular dystrophy (DMD): an external pilot randomised controlled trial |
title_full | Aquatic therapy for boys with Duchenne muscular dystrophy (DMD): an external pilot randomised controlled trial |
title_fullStr | Aquatic therapy for boys with Duchenne muscular dystrophy (DMD): an external pilot randomised controlled trial |
title_full_unstemmed | Aquatic therapy for boys with Duchenne muscular dystrophy (DMD): an external pilot randomised controlled trial |
title_short | Aquatic therapy for boys with Duchenne muscular dystrophy (DMD): an external pilot randomised controlled trial |
title_sort | aquatic therapy for boys with duchenne muscular dystrophy (dmd): an external pilot randomised controlled trial |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367005/ https://www.ncbi.nlm.nih.gov/pubmed/28357131 http://dx.doi.org/10.1186/s40814-017-0132-0 |
work_keys_str_mv | AT hinddaniel aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial AT parkinjames aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial AT whitworthvictoria aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial AT rexsaleema aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial AT youngtracey aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial AT hampsonlisa aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial AT sheehanjennie aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial AT maguirechin aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial AT cantrillhannah aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial AT scottelaine aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial AT eppsheather aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial AT mainmarion aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial AT gearymichelle aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial AT mcmurchieheather aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial AT pallantlindsey aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial AT woodsdaniel aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial AT freemanjennifer aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial AT leeellen aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial AT eaglemichelle aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial AT willistracey aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial AT muntonifrancesco aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial AT baxterpeter aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial |